Leptin receptor 170 kDa (OB‐R170) protein expression is reduced in obese human skeletal muscle: a potential mechanism of leptin resistance
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
To examine whether obesity‐associated leptin resistance could be due to down‐regulation of leptin receptors (OB‐Rs) and/or up‐regulation of suppressor of cytokine signalling 3 (SOCS3) and protein tyrosine phosphatase 1B (PTP1B) in skeletal muscle, which blunt janus kinase 2‐dependent leptin signalling and signal transducer and activator of transcription 3 (STAT3) phosphorylation and reduce AMP‐activated protein kinase (AMPK) and acetyl‐coenzyme A carboxylase (ACC) phosphorylation. Deltoid and vastus lateralis muscle biopsies were obtained from 20 men: 10 non‐obese control subjects (mean ±s.d. age, 31 ± 5 years; height, 184 ± 9 cm; weight, 91 ± 13 kg; and percentage body fat, 24.8 ± 5.8%) and 10 obese (age, 30 ± 7 years; height, 184 ± 8 cm; weight, 115 ± 8 kg; and percentage body fat, 34.9 ± 5.1%). Skeletal muscle OB‐R170 (OB‐R long isoform) protein expression was 28 and 25% lower (both P < 0.05) in arm and leg muscles, respectively, of obese men compared with control subjects. In normal‐weight subjects, SOCS3 protein expression, and STAT3, AMPKα and ACCβ phosphorylation, were similar in the deltoid and vastus lateralis muscles. In obese subjects, the deltoid muscle had a greater amount of leptin receptors than the vastus lateralis, whilst SOCS3 protein expression was increased and basal STAT3, AMPKα and ACCβ phosphorylation levels were reduced in the vastus lateralis compared with the deltoid muscle (all P < 0.05). In summary, skeletal muscle leptin receptors and leptin signalling are reduced in obesity, particularly in the leg muscles.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The JAK-STAT Signaling Pathway: Input and Output Integration
Murray, P. J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.5.2623 · Cited by 1,179
Mechanisms of leptin action and leptin resistance.
Myers, M. G., Cowley, M. A., & Münzberg, H. (2008) · Annual Review of Physiology · doi:10.1146/annurev.physiol.70.113006.100707 · Cited by 1,074 · cited 3×
“Email: lopezcalbet@gmail.com Human obesity is characterized by increased leptin concentration in plasma, as well as leptin (Steinberg et al. 2002b; Bates & Myers, 2003; Anubhuti & Arora, 2008; Myers et al. 2008) and insulin resistance (Olefsky et al. 1982).”
BackgroundSTAT3 signalling is required for leptin regulation of energy balance but not reproduction
Bates, S. H., Stearns, W. H., Dundon, T. A., Schubert, M., Tso, A. W. K., Wang, Y., Banks, A. S., Lavery, H. J., Haq, A. K., Maratos-Flier, E., et al. (2003) · Nature · doi:10.1038/nature01388 · Cited by 1,010 · cited 9×
“Leptin may also downregulate leptin signalling in the target tissues by inducing the protein suppressor of cytokine signalling 3 (SOCS3), which blunts JAK2/STAT3-dependent leptin signalling (Bjørbæk et al. 2000) and causes leptin resistance in the skeletal muscle (Steinberg et al. 2006c).”
BackgroundInfluentialActivation of Downstream Signals by the Long Form of the Leptin Receptor
Banks, A. S., Davis, S. M., Bates, S. H., & Myers, M. G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.19.14563 · Cited by 797
SOCS3 Mediates Feedback Inhibition of the Leptin Receptor via Tyr985
Bjørbæk, C., Lavery, H. J., Bates, S. H., Olson, R. K., Davis, S. M., Flier, J. S., & Myers, M. G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m007577200 · Cited by 537 · cited 3×
“The OB-R170 isoform could very well be the main ligand for leptin in skeletal muscle (Bjørbæk et al. 2000).”
BackgroundProtein-tyrosine phosphatase 1B expression is induced by inflammation in vivo.
Zabolotny, J. M., Kim, Y.-B., Welsh, L. A., Kershaw, E. E., Neel, B. G., & Kahn, B. B. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800061200 · Cited by 404 · cited 2×
“Protein tyrosine phosphatase 1B (PTP1B) is also a negative regulator of leptin and insulin signalling (Dube & Tremblay, 2005) that may be increased in skeletal muscle by inflammation (Zabolotny et al. 2008).”
BackgroundBandyopadhyay, G. K., Yu, J. G., Ofrecio, J., & Olefsky, J. M. (2006) · Diabetes · doi:10.2337/db06-0062 · Cited by 291
Steinberg, G. R., Parolin, M. L., Heigenhauser, G. J. F., & Dyck, D. J. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00542.2001 · Cited by 207 · cited 5×
“…is reduced in obesity, since the hormone is unable to increase the fatty acid oxidation in human obese skeletal muscle in vitro (Steinberg et al. 2002b), and chronic leptin administration decreases fatty acid uptake and fatty acid transporters in rat skeletal muscle (Steinberg et al. 2002a).”
BackgroundInfluentialAMP-Activated Protein Kinase Is Not Down-Regulated in Human Skeletal Muscle of Obese Females
Steinberg, G. R., Smith, A. C., van Denderen, B. J. W., Chen, Z., Murthy, S., Campbell, D. J., Heigenhauser, G. J. F., Dyck, D. J., & Kemp, B. E. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0308 · Cited by 97 · cited 3×
“Another study found no differences between obese and control women in AMPK activity and Ser221ACCβ phosphorylation in the rectus abdominis muscle (Steinberg et al. 2004a).”
BackgroundSteinberg, G. R., Dyck, D. J., Calles-Escandon, J., Tandon, N. N., Luiken, J. J. F. P., Glatz, J. F. C., & Bonen, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107683200 · Cited by 91
Cited by
Physiology of leptin: energy homeostasis, neuroendocrine function and metabolism
Park, H.-K., & Ahima, R. S. (2015) · Metabolism · doi:10.1016/j.metabol.2014.08.004 · Cited by 669
Sarcopenia: assessment of disease burden and strategies to improve outcomes
Liguori, I., Russo, G., Aran, L., Bulli, G., Curcio, F., Della-Morte, D., Gargiulo, G., Testa, G., Cacciatore, F., Bonaduce, D., et al. (2018) · Clinical Interventions in Aging · doi:10.2147/cia.s149232 · Cited by 300
Sarcopenic obesity: Emerging mechanisms and therapeutic potential
Axelrod, C. L., Dantas, W. S., & Kirwan, J. P. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155639 · Cited by 204
Leptin in Sarcopenic Visceral Obesity: Possible Link between Adipocytes and Myocytes
Kohara, K., Ochi, M., Tabara, Y., Nagai, T., Igase, M., & Miki, T. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024633 · Cited by 99
“Given that obesity is associated with reduced number and function of leptin receptors in leg muscle [24], these present and previous findings suggest that impaired action of leptin in skeletal muscle may also induce development of sarcopenia.”
BackgroundAkbarpour, M. (2013) · Biology of Sport · doi:10.5604/20831862.1029817 · Cited by 48
Metadata
- Authors
- Fuentes, T., Ara, I., Guadalupe‐Grau, A., Larsen, S., Stallknecht, B., Olmedillas, H., Santana, A., Helge, J. W., Calbet, J. A. L., & Guerra, B.
- Venue
- Experimental Physiology
- Publisher
- Wiley
- Published
- 2009-12-15
- Volume
- 95
- Issue
- 1
- Pages
- 160-171
- ISSN
- 0958-0670 (ISSN-L)
- 1469-445X
- OpenAlex
- W2114887612
- Cited by
- 62
- References
- 10
- FWCI
- 2.05
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Leptin receptor 170 kDa (OB‐R170) protein expression is reduced in obese human skeletal muscle: a potential mechanism of leptin resistance. https://app.cochat.ai/papers/10.1113/expphysiol.2009.049270
- The paper
- Fuentes, T., Ara, I., Guadalupe‐Grau, A., Larsen, S., Stallknecht, B., Olmedillas, H., Santana, A., Helge, J. W., Calbet, J. A. L., & Guerra, B. (2010). Leptin receptor 170 kDa (OB‐R170) protein expression is reduced in obese human skeletal muscle: a potential mechanism of leptin resistance. Experimental Physiology. https://doi.org/10.1113/expphysiol.2009.049270
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.